Orexigen Therapeutics Inc (NASDAQ:OREX)

7.54
Delayed Data
As of Mar 27
 +0.29 / +4.00%
Today’s Change
3.11
Today|||52-Week Range
9.37
+24.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues857.0K857.0K30.9M23.0M
 
 
 
 
 
Depreciation And Amortization8.0K38.0K41.0K52.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses24.0M23.6M17.8M20.5M
 
 
 
 
 
Research And Development17.0M16.7M10.7M13.0M
 
 
 
 
 
Total Operating Expenses24.0M23.7M17.8M20.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-23.2M-22.8M13.0M2.4M
 
 
 
 
 
Interest Expense On Debt1.8M1.7M1.8M1.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-24.9M-24.5M11.3M607.0K
 
 
 
 
 
Net Income-24.9M-24.5M11.3M607.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS109.2M118.0M122.6M123.0M
 
 
 
 
 
Shares To Calculate EPS Diluted109.2M118.0M130.1M123.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.23-$0.21$0.09$0.00
 
 
 
 
EPS Diluted-$0.23-$0.21$0.09$0.00
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account